Canaccord lowered the firm’s price target on Bioceres (BIOX) to $9.50 from $10 and keeps a Buy rating on the shares. The firm said while the Q1 print confirmed our previous expectation that farmers in Latin America would take a bit longer to recover from El Nino drought trends, we believe that normalizing Argentinian rainfall suggests the weather headwinds are subsiding and could enable a Q2 recovery
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BIOX: